Financial Trade Freedom - Investing and Stock News
  • Investing
  • News
  • Editor’s Pick
  • Economy
  • Stock
  • Investing
  • News
  • Editor’s Pick
  • Economy
  • Stock
No Result
View All Result
Financial Trade Freedom - Investing and Stock News
No Result
View All Result
Home News

‘Held accountable’: Sen. Rand Paul again vows to issue a criminal referral for Fauci

admin by admin
July 14, 2025
in News
0
‘Held accountable’: Sen. Rand Paul again vows to issue a criminal referral for Fauci
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

Sen. Rand Paul, R-Ky., on Monday announced that he would revive his criminal referral against Dr. Anthony Fauci, adding yet another wrinkle to the ongoing Biden White House autopen saga.

‘Today I will reissue my criminal referral of Anthony Fauci to Trump DOJ,’ Paul said on X.

It’s not the first time that Paul has issued a criminal referral against Fauci, who is the former director of the National Institute of Allergy and Infectious Diseases (NIAID) and medical adviser to former President Joe Biden.

The first came in 2021, when Paul accused Fauci of lying to Congress about funding gain-of-function research for the COVID-19 virus at the Wuhan Institute of Virology. The next came in 2023, again as part of Paul’s efforts to investigate the origins of the virus.

‘Perjury is a crime,’ Paul said. ‘And Fauci must be held accountable.’

Fox News Digital reached out to Paul’s office for comment.

This time, Paul’s reupping of his criminal referral comes after a new report added another chapter to the ongoing autopen saga, in which President Donald Trump and congressional Republicans have accused Biden of shrugging off his authority to aides and top officials in the White House to authorize his signature on a slew of pardons and documents.

The New York Times reported that emails showed that Biden’s Chief of Staff Jeff Zients gave final approval for the use of the autopen for preemptive pardons for Fauci and former Joint Chiefs of Staff Gen. Mark Milley, two of Trump’s top critics.  

Biden signed the bulk of his over 4,000 clemency documents in the waning months of his presidency, a point that Trump and congressional Republicans have pounced to hammer in the claims that the former president’s cognitive ability was declining and his staff were running the White House.

Trump has gone so far as to request Attorney General Pam Bondi open an investigation into Biden’s usage of the autopen, while Republicans in the Senate and House have all held their own committee hearings on the matter.

And earlier Monday, Trump told reporters that Biden’s alleged use of the autopen amounted to possibly ‘one of the biggest scandals that we’ve had in 50 to 100 years.’

‘I guarantee you he knew nothing about what he was signing, I guarantee you,’ Trump said. 

Diana Stancy contributed to this report. 

This post appeared first on FOX NEWS

Previous Post

Top 4 catalysts for the S&P 500 Index and its ETFs like VOO and SPY

Next Post

Biden chief of staff reportedly gave approval for autopen pardons on final day in office

Next Post
Biden chief of staff reportedly gave approval for autopen pardons on final day in office

Biden chief of staff reportedly gave approval for autopen pardons on final day in office

  • Trending
  • Comments
  • Latest
U.S. homebuilders raise alarm over tariffs as sentiment falls to 5-month low

U.S. homebuilders raise alarm over tariffs as sentiment falls to 5-month low

February 19, 2025
How Companies Use Derivatives To Hedge Risk

How Companies Use Derivatives To Hedge Risk

February 19, 2025
As Joann Fabrics and JCPenney announce store closings, here’s what’s driving the pattern

As Joann Fabrics and JCPenney announce store closings, here’s what’s driving the pattern

February 17, 2025
KFC moves U.S. headquarters from Kentucky to Texas

KFC moves U.S. headquarters from Kentucky to Texas

February 19, 2025
Why Friday’s sell-off in S&P 500 was not surprising and what comes next

Why Friday’s sell-off in S&P 500 was not surprising and what comes next

0
From tariffs to DOGE, what companies are saying about the impact of MAGA policies

From tariffs to DOGE, what companies are saying about the impact of MAGA policies

0
Tesla’s law firm drafts Delaware bill that could salvage Musk pay package

Tesla’s law firm drafts Delaware bill that could salvage Musk pay package

0
Coca-Cola takes on Olipop and Poppi with new prebiotic soda brand, Simply Pop

Coca-Cola takes on Olipop and Poppi with new prebiotic soda brand, Simply Pop

0
Why Friday’s sell-off in S&P 500 was not surprising and what comes next

Why Friday’s sell-off in S&P 500 was not surprising and what comes next

August 3, 2025
Here’s what will affect the Nikkei 225 Index this week

Here’s what will affect the Nikkei 225 Index this week

August 3, 2025
FTSE 100 Index shares to watch: IHG, Legal & General, Flutter, BP

FTSE 100 Index shares to watch: IHG, Legal & General, Flutter, BP

August 3, 2025
Here’s what will affect the Nikkei 225 Index this week

Here’s what will affect the Nikkei 225 Index this week

August 3, 2025

    Get Smarter with Your Money – Sign Up for Free Financial Tips!


    Join our community of savvy savers and investors! By signing up, you'll receive weekly emails packed with personalized financial tips, budgeting hacks, and investment strategies tailored to your income level. Take control of your finances today – it’s free and only takes a minute!

    Recent News

    Why Friday’s sell-off in S&P 500 was not surprising and what comes next

    Why Friday’s sell-off in S&P 500 was not surprising and what comes next

    August 3, 2025
    Here’s what will affect the Nikkei 225 Index this week

    Here’s what will affect the Nikkei 225 Index this week

    August 3, 2025
    FTSE 100 Index shares to watch: IHG, Legal & General, Flutter, BP

    FTSE 100 Index shares to watch: IHG, Legal & General, Flutter, BP

    August 3, 2025
    Here’s what will affect the Nikkei 225 Index this week

    Here’s what will affect the Nikkei 225 Index this week

    August 3, 2025
    • About us
    • Contacts
    • Privacy Policy
    • Terms and Conditions
    • Email Whitelisting
    • About us
    • Contacts
    • Privacy Policy
    • Terms and Conditions
    • Email Whitelisting

    Disclaimer: FinancialTradeFreedom.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 financialtradefreedom.com | All Rights Reserved

    No Result
    View All Result
    • About us
    • Contacts
    • Email Whitelisting
    • Investing and Stock News
    • Privacy Policy
    • Terms and Conditions
    • Thank you

    Disclaimer: FinancialTradeFreedom.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 financialtradefreedom.com | All Rights Reserved